Eloquest Healthcare News and Events
Eloquest Healthcare and TillaCare Form New Partnership for UriCap™ Female Distribution in U.S. Acute Care Hospitals
Eloquest Healthcare is excited to announce our new partnership with TillaCare founded on a shared goal of reducing catheter-associated urinary tract infection (CAUTI) risk in U.S. hospitals.
Through collaboration, medical device companies can leverage each other’s strengths to satisfy patients and providers.
Eloquest Healthcare, Inc. is honored to announce today announced that it is Great Place to Work-Certified™ for 2019-2020!
Eloquest Healthcare, Inc. is honored to announce that Fortune and Great Place to Work have recognized us as one of the 2018 Best Workplaces in Health Care & Biopharma!
Eloquest Healthcare is proud to be named Great Place to Work and Fortune Magazine’s Best Workplaces for Small Medium Business Companies, read more about it here!
Vancive Medical Technologies™, an Avery Dennison (NYSE:AVY) business, and Eloquest Healthcare®, Inc. have partnered to develop an innovative post-operative dressing that contains an antimicrobial agent called chlorhexidine gluconate (CHG). The antimicrobial properties of CHG inhibit microbial growth within the dressing
To raise awareness about the importance of infection prevention, Eloquest Healthcare is joining the Association for Professionals in Infection Control and Epidemiology (APIC) as a corporate Champion for International Infection Prevention Week (IIPW), October 15-21.